|Other Names||Ubiquitin-conjugating enzyme E2 H, UbcH2, Ubiquitin carrier protein H, Ubiquitin-conjugating enzyme E2-20K, Ubiquitin-protein ligase H, UBE2H|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys- 11'- and 'Lys-48'-linked polyubiquitination. Capable, in vitro, to ubiquitinate histone H2A.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The modification of proteins with ubiquitin is animportant cellular mechanism for targeting abnormal or short-livedproteins for degradation. Ubiquitination involves at least threeclasses of enzymes: ubiquitin-activating enzymes, or E1s,ubiquitin-conjugating enzymes, or E2s, and ubiquitin-proteinligases, or E3s. This gene encodes a member of the E2ubiquitin-conjugating enzyme family. The encoded protein sequenceis 100% identical to the mouse homolog and 98% identical to thefrog and zebrafish homologs. Two alternatively spliced transcriptvariants have been found for this gene and they encode distinctisoforms.
Lausen, J., et al. J. Biol. Chem. 285(8):5338-5346(2010)Martin, I., et al. Amyotroph Lateral Scler 10 (5-6), 432-435 (2009) :de Krom, M., et al. Biol. Psychiatry 65(7):625-630(2009)Martin, I., et al. Amyotroph Lateral Scler, 1-4 (2008) In press :Kim, H.J., et al. Immunol. Lett. 95(2):155-159(2004)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.